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Abstract
 
Distinguishing between the development of functional potential in antigen-specific T helper
(Th) cells and the delivery of these specialized functions in vivo has been difficult to resolve.
Here, we quantify the frequency of cytokine-producing cells within the primary and memory
B10.BR Th cell response to pigeon cytochrome c (PCC). In vitro analysis of acquired func-
tional potential indicated no Th1/Th2 cytokine polarity at the peak of the primary response
with surprisingly little evidence for the selective preservation of interleukin (IL)-2, tumor ne-
crosis factor (TNF)-
 
a
 
, IL-4, and interferon (IFN)-
 
g
 
 potentials into the memory compartment.
However, the expression of these functional potentials appears tightly regulated in vivo. The
staggered appearance of primary response cytokines directly ex vivo contrasts markedly with
their rapid coordinate expression in the memory response. Frequencies of IL-2–, TNF-
 
a
 
–,
IFN-
 
g
 
–, and IL-10–expressing memory responders increased over their primary response
counterparts, but were still markedly lower than revealed in vitro. IL-4–, IFN-
 
g
 
–, and IL-10–
expressing Th cells remained at low but stable frequencies over the first 6 d of the memory re-
sponse. Analysis of T cell receptor 
 
b
 
 chain sequences of IL-4– and TNF-
 
a
 
–expressing PCC-
specific Th cells provides evidence for early functional commitment among clonal progeny.
These data indicate that the development of functional potential is a consequence of initial an-
tigen experience, but delivery of specialized functions is differentially regulated in primary and
memory immune responses.
Key words: immunological memory • cytokines • antigen-speciﬁc immunity • helper T cells • 
T cell receptor
 
Introduction
 
Memory Th cells are critical regulators of long-term pro-
tective immunity. The cardinal sign of a memory Th cell
response is the accelerated emergence of antigen-specific
Th cells upon antigen rechallenge in vivo (1–4). In the
B10.BR response to pigeon cytochrome c (PCC),
 
1 
 
clonal
expansion in the memory response reaches maximal levels
4 d faster than seen after initial antigen priming (3, 4).
These memory responders express restricted V region
genes (V
 
a
 
11V
 
b
 
3) with TCR junctional features known to
confer peptide specificity (5–8). Selection of these PCC-
specific Th cells with preferred TCR occurs rapidly after
initial priming, they are propagated through clonal expan-
sion, and then are preserved as precursors for the memory
response (3, 4). Antigen-experienced Th cells rapidly pro-
duce cytokines at lower doses of antigen, displaying low-
ered requirements for costimulation (9–11). This rapid ap-
pearance of effector Th cell function and increased levels of
cytokines accompany accelerated cellular expansion in the
memory response (1, 2, 12–14). Thus, antigen-specific Th
cells that have committed to the production of preferred
cytokines may be selectively retained in the memory com-
partment.
Naive Th cells produce a limited range of cytokines with
mitogen stimulus in vitro. Upon exposure to antigen in
vivo, Th cells can commit to the production of many dif-
ferent cytokines through preexisting intrinsic mechanisms
(15–18) and are influenced to varying degrees by extrinsic
factors that induce transcriptional (19–21) and heritable lo-
cus-specific genetic changes (16, 22, 23). The patterns of
functional commitment were initially classified into Th
cells that produced either type 1 (IL-2, TNF-
 
b
 
, IFN-
 
g
 
) or
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type 2 (IL-4, IL-5, IL-6, IL-10) cytokines, with some cy-
tokines found in both (IL-3 and TNF-
 
a
 
) (24, 25). There
are now many exceptions to this initial Th1/Th2 schematic
(26–30), with gene expression patterns at the single cell
level being more consistent with independent cytokine
gene regulation (31, 32). Distinguishing between this de-
velopment of functional potential as a consequence of anti-
gen experience and the expression of these potentials as ef-
fector functions in vivo has not been adequately addressed.
Cytokine production is still generally assessed after short-
term restimulation in vitro
 
 
 
(1, 2, 12, 26, 33). Even sensitive
enzyme-linked immunospot assays require an antigen pulse
to reveal cytokine production in vitro (34, 35). These
short-term restimulation assays exaggerate the frequencies
of cells expressing cytokine mRNA directly ex vivo
 
 
 
(36,
37). TCR transgenic Th cells have been elegantly used to
monitor specific Th cell responses (12, 13, 33, 38), and fre-
quency estimates for cytokine mRNA expression directly
ex vivo are very low, even in memory responses using
these models (13). Therefore, it still remains unclear
whether cytokine production in vivo
 
 
 
is regulated by con-
trolling the numbers of antigen-specific Th cells committed
to particular functions or through the differential expres-
sion of their functional potentials.
In this study, we analyze cytokine production in single
PCC-specific Th cells from B10.BR mice. A great deal is
known about the cellular dynamics of the PCC-specific pri-
mary and memory response (3–5), the TCR structure and
affinity for antigen (6–8, 39), the kinetics of clonal selec-
tion, and the preservation of clonal dominance in this re-
sponse (3, 4, 8). Although it is possible to isolate PCC-
specific Th cells using moth cytochrome c (MCC)/I-E
 
k
 
tetramers (39; and McHeyzer-Williams, L.J., unpublished
results), these reagents effectively cross-link the TCR and
hence are not ideal for subsequent analysis of function (40).
We use an alternate cell purification strategy with anti-
TCR antibodies (anti-V
 
a
 
11V
 
b
 
3) and comodulation of cell
surface molecules (CD44 upregulation and CD62L down-
regulation) that isolates PCC-specific Th cells regardless of
TCR affinity for peptide–MHC (3, 4) and does not induce
calcium transients during cell preparation and isolation (41.
Further, we use whole protein antigen and a nondepot ad-
juvant system (Ribi, an LPS derivative in a metabolizable
oil) that efficiently induces high titer antibody responses
with isotype switch to IgG1, IgG2a/2b, and IgE (42, 43).
Hence, the activity of the PCC-responsive Th cells is fo-
cused in the draining LNs to induce (a) Th cell prolifera-
tion, implicating IL-2 and TNF-
 
a
 
 expression (44, 45); (b)
isotype switch in B cells, implicating IL-4 and IFN-
 
g
 
 ex-
pression (46, 47); and (c) efficient antibody secretion by
plasma cells, implicating IL-6 and IL-10 expression (48–50).
Using short-term mitogen stimulation in vitro and a sin-
gle cell reverse transcription (RT)-PCR assay for expres-
sion of cytokine mRNA directly ex vivo, we provide di-
rect quantitative analysis of cytokine production in PCC-
specific Th cells. The mitogen restimulation assay provides
one indication of antigen-driven commitment to function,
and the RT-PCR assay quantifies the frequency of PCC-
 
specific cells that actually express a particular function at
any specified time during the immune response. Surpris-
ingly, there was no change in the functional potential of
PCC-specific Th cells between the peak of the primary re-
sponse and the peak of the memory response for IL-2,
TNF-
 
a
 
, IL-4, and IFN-
 
g
 
. Further, there were relatively
low frequencies of PCC-specific cells committed to pro-
duce IL-4, IFN-
 
g
 
, and IL-10 as a consequence of initial
antigen experience. The expression of cytokines directly ex
vivo varied in frequency and kinetics between primary and
memory response. The primary cytokine response to PCC
was dominated by IL-4
 
1
 
 (day 9: 10.2 
 
6 
 
4.6%), some TNF-
 
a
 
1
 
(day 9: 2.7 
 
6 
 
1.2%), very few IFN-
 
g
 
1
 
 (day 9: 0.4 
 
6 
 
0.4%),
and sporadic IL-10
 
1
 
 and IL-6
 
1
 
 Th cells directly ex vivo. In
the memory response, IL-2
 
1
 
, TNF-
 
a
 
1
 
, IL-4
 
1
 
, IFN-
 
g
 
1
 
,
and IL-10
 
1
 
 PCC-specific Th cells emerged rapidly after
recall, with no evidence for IL-6
 
1
 
 cells. Frequencies for
IL-4
 
1
 
 Th cells remained the same while all the other ex-
pressed cytokines increased in prevalence. Thus, expression
of preferred memory function is not simply a reflection of
the increased functional capacity of the memory Th cells;
rather, their accelerated expression and increased preva-
lence appear differentially regulated by the microenviron-
ment of the memory response.
 
Materials and Methods
 
Animals and Immunization.
 
5–8-wk-old B10.BR mice were
purchased from The Jackson Laboratory and housed in patho-
gen-free conditions at the Duke University Vivarium. Mice were
immunized with 400 
 
m
 
g whole PCC (Sigma-Aldrich) in PBS
emulsified with 200 
 
m
 
l Ribi adjuvant (Ribi ImmunoChem Re-
search, Inc.) by two injections at each side of the base of tail. To
examine a secondary response, mice were rechallenged 8 wk af-
ter the primary immunization with the same 400 
 
m
 
g PCC in 200
 
m
 
l Ribi adjuvant.
 
Flow Cytometry.
 
For population and single cell analysis of cy-
tokine expression by RT-PCR, mice were killed at different days
after immunization. The inguinal and periaortic LNs were re-
moved, and red blood cells were lysed with 0.17 M NH
 
4
 
Cl. The
remaining cells were resuspended in PBS containing 5% FCS and
stained at 2 
 
3
 
 10
 
8
 
 cells/ml with the appropriate concentrations
of antibodies. For sorting of PCC-specific Th cells, LN cells
were stained with Cy5PE-53-6.7 (anti-CD8; BD PharMingen),
Cy5PE-M1/70.15 (anti-CD11b; Caltag), Cy5PE-6B2 (anti-
B220; BD PharMingen), FITC-RR8.1 (anti-V
 
a
 
11; BD Phar-
Mingen), allophycocyanin (APC)-KJ25 (anti-V
 
b
 
3), PE-Mel14
(anti-CD62L; BD PharMingen), and biotin-IM7 (anti-CD44;
BD PharMingen). For MCC/I-E
 
k
 
 tetramer staining (a gift from
M.M. Davis and J.D. Altman, Stanford University, Palo Alto,
CA), the anti-V
 
b
 
3 was replaced with a PE–tetramer conjugate
used with the same combination of antibodies outlined above
with Texas red (TR)-Mel14 and APC-IM7 on different fluoro-
phores (accounting for slightly different mean fluorescence inten-
sities). After washing twice with PBS containing 5% FCS, the
cells were stained at 2 
 
3
 
 10
 
8
 
 cells/ml with streptavidin-TR (BD
PharMingen). Cells were washed and resuspended in PBS con-
taining 5% FCS and 2 
 
m
 
g/ml propidium iodide to label dead
cells. The cells were analyzed using a dual laser modified FAC-
Star
 
PLUS™
 
 (Becton Dickinson) capable of seven parameter simul- 
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taneous collection then analyzed using FlowJo software (Treestar)
as described previously (4).
 
In Vitro Activation.
 
To examine the cytokine-expressing po-
tential of PCC-specific Th cells, cells were isolated from the in-
guinal and periaortic LNs of B10.BR mice at day 9 of the pri-
mary response and day 3 of the secondary response. After red cell
lysis and resuspension in PBS containing 5% FCS, cells were cul-
tured at 2 
 
3
 
 10
 
6
 
 cells/ml in RPMI 1640 (GIBCO BRL) contain-
ing 10% FCS with or without 50 ng/ml PMA (Sigma-Aldrich)
and 500 ng/ml ionomycin (Sigma-Aldrich) for 4 h at 37
 
8
 
C.
Brefeldin A (5 
 
m
 
g/ml; Sigma-Aldrich) was added at the start of
the culturing. Cells were washed with PBS containing 5% FCS
and resuspended in the same with 10 
 
m
 
g/ml brefeldin A added.
Cells were stained for analysis by flow cytometry (see above).
To compare the frequency of CD4
 
1
 
 
 
T cells expressing IL-2,
IFN-
 
g
 
, or TNF-
 
a
 
 determined by intracellular staining and RT-
PCR (see Fig. 3), spleen cells from unimmunized B10.BR mice
were isolated and activated in vitro with PMA and ionomycin as
described above. To compare the frequency of cells expressing
IL-4 or IL-10, C57BL/6 mice were immunized intraperitoneally
with 400 
 
m
 
g NP-KLH in Ribi adjuvant and killed 7 d later.
Spleen cells were isolated and activated in vitro with PMA and
ionomycin as described above. Cells were harvested and stained
for analysis by flow cytometry.
 
Intracellular Staining for Cytokines.
 
Cells were stained for intra-
cellular cytokines using the protocol described by Openshaw et
al. (29). Cells cultured with or without PMA and ionomycin
were stained for surface antigens at a concentration of 2 
 
3
 
 10
 
8
 
cells/ml. To evaluate the cytokine-expressing potential of anti-
gen-specific cells, cultured LN cells from day 9 of the primary re-
sponse or day 3 of the memory response were stained with
Cy5PE-53-6.7 (anti-CD8; BD PharMingen), Cy5PE-M1/70.15
(anti-CD11b; Caltag), Cy5PE-6B2 (anti-B220; BD PharMin-
gen), FITC-RR8.1 (anti-V
 
a
 
11; BD PharMingen), APC-KJ25
(anti-V
 
b
 
3), and TR–Pgp-1 (anti-CD44). After surface staining,
cells were fixed for 20 min with 2% formaldehyde, then perme-
abilized in PBS containing 5% FCS, 1% BSA (Boehringer), and
0.5% saponin (Sigma-Aldrich) for 10 min. Cells were stained in
this permeabilization buffer with PE-conjugated antibodies di-
rected toward each cytokine: PE-S4B6 (anti–IL-2), PE–MP6-
XT22 (anti–TNF-
 
a
 
), PE-XMG1.2 (anti–IFN-
 
g
 
), PE–BVD4-
1D11 (anti–IL-4), and PE–JES5-16E3 (anti–IL-10) (all reagents
were purchased from BD PharMingen). After washing twice
with PBS/FCS/BSA/saponin, cells were washed with PBS/
FCS/BSA then resuspended in PBS with 5% FCS and analyzed
by flow cytometry.
To compare the frequency of CD4
 
1
 
 
 
T cells expressing each
cytokine as determined by intracellular staining and RT-PCR,
cultured spleen cells were stained with Cy5PE-53-6.7 (anti-
CD8; BD PharMingen), Cy5PE-M1/70.15 (anti-CD11b; Cal-
tag), Cy5PE-6B2 (anti-B220; BD PharMingen), TR–Pgp-1
(anti-CD44), and FITC–CT-CD4 (anti-CD4; Caltag). One half
of the stained cells remained on ice until cell sorting. The remain-
der of the stained cells were fixed, permeabilized, and stained for
intracellular cytokines as described above.
 
cDNA Synthesis.
 
Cells with the appropriate surface pheno-
type, 100 or 200 cells for population analysis or single cells, were
sorted directly into 5 
 
m
 
l of an oligo d(T)–primed cDNA reaction
mixture. This reaction mixture contained 4 U/ml MLV-RT
(GIBCO BRL) with its recommended 1
 
3
 
 buffer, 0.5 nM sper-
midine (Sigma-Aldrich), 100 
 
m
 
g/ml BSA (Boehringer), 10 ng/
 
m
 
l
oligo d(T) (Becton Dickinson), 200 
 
m
 
M each dNTP (Boeh-
ringer), 1 mM dithiothreitol (Promega), 220 U/ml RNAsin
(Promega), 100 
 
m
 
g/ml 
 
Escherichia coli 
 
tRNA (Boehringer), and
1% Triton X-100. cDNA was synthesized immediately at 37
 
8
 
C
for 90 min then stored at 
 
2
 
80
 
8
 
C until further use. Single cells
 
Table I.
 
Primer Sets for Cytokine PCR (5
 
9
 
–3
 
9
 
)
 
IL-2 Ext S
 
CTCGCATCCTGTGTCACATGG
 
IFN-
 
g
 
Ext S
 
GGCTGTTTCTGGCTGTTACTG
 
Ext A
 
CTCGCATCCTGTGTCACATGG
 
Ext A
 
TTGTTACTATAAATACTTCTTTGG
 
Int S
 
CTACAGCGGAAGCACAGCAG
 
Int S
 
CCCCACCCCGAATCAGCAGCGACTC
 
Int A
 
GCACTCAAATGTGTTGTCAG
 
9
 
Int A
 
TCTGGAGGAACTGGCAAAAGGATGG
 
IL-4 Ext S
 
CATCCTGCTCTTCTTTCTCG
 
TNF-
 
a
 
Ext S
 
CGTGGAACTGGCAGAAGAGG
 
Ext A
 
GTACTACGAGTAATCCATTTG
 
Ext A
 
GGGGCAGGGGCTCTTGACGGC
 
Int S
 
CACTTGAGAGAGATCATCGG Int S CTTCCAGAACTCCAGGCGGTG
Int A CTTTCAGTGATGTGGACTTGG Int A GCTGACGGTGTGGGTGAGGAG
IL-6 Ext S CATCCAGTTGCCTTCTTGGG Actin Ext S GACCCTGAAGTACCCCATTG
Ext A TCCTTAGCCACTCCTTCTGTG Ext A GTAATCTCCTTCTGCATCCTG
Int S CTTCCCTACTTCACAAGTCCG Int S GGGACGACATGGAGAAGATC
Int A TTGGAAATTGGGGTAGGAAGG Int A AGGTCTTTACGGATGTCAACG
IL-10 Ext S CTATGCTGCCTGCTCTTACT
Ext A GTAGACACCTTGGTCTTGGAG
Int S CTGCGGACTGCCTTCAGCCAG
Int A TTCACCTGCTCCACTGCCTTG
Ext S, external primer (sense); Ext A, external primer (antisense); Int S, internal primer (sense); Int A, internal primer (antisense).1304 Selective Cytokine Expression In Vivo
were sorted into cDNA reaction mix in low profile, 72-well mi-
crotiter trays (Robbins Scientific) using the automatic cell dis-
pensing unit (ACDU) attached to the FACStarPLUS™ (Becton
Dickinson) and Clone-Cyt™ software (Becton Dickinson).
Nested PCR. PCR conditions were optimized for each cy-
tokine. 2.5–5.0 ml of cDNA was added to a reaction mixture
containing 2 U/ml Taq polymerase and corresponding 13 reac-
tion buffer (Promega), 0.4 mM dNTPs (Boehringer), and 0.4
mM of each external primer (Genosys; as listed in Table I). The
first PCR reaction consisted of 5 min at 958C, 40 cycles of 958C
for 15 s, 508C for 45 s, and 728C for 90 s, followed by 5 min at
728C. 1.0 ml of this first reaction mixture was transferred to a sec-
ond reaction containing 2 U/ml Taq polymerase and correspond-
ing 13 reaction buffer (Promega), 0.2 mM dNTPs (Boehringer),
and 0.8 mM of each internal primer (Genosys). The second PCR
reaction consisted of 5 min at 958C, 35 (IL-4, IL-6, IL-10, TNF-a,
and actin) or 40 (IL-2 and IFN-g) cycles of 958C for 15 s, 558C
for 45 s, and 728C for 90 s, followed by 5 min at 728C. PCR
product was viewed on a 2% agarose gel stained with ethidium
bromide. cDNA was analyzed for the presence of actin to control
for the accuracy of cell sorting. If the frequency of actin-positive
cell samples dropped below 65%, the calculated frequency of cy-
tokine producing cells was adjusted. This occurred in 6/33 plates
sampled for actin.
TCR Sequencing. To assess the Vb3 TCR sequence from
cells expressing IL-4 or TNF-a, one half of the cDNA from a
single cell sorted at day 9 of the primary response was analyzed
for the presence of each cytokine. If the cells expressed either cy-
tokine, the remaining cDNA was amplified with primers specific
for Vb3 and sequenced as described (4). In brief, 2.5 ml of cDNA
was added to a reaction mixture containing 2 mM MgCl2, 0.1
mM of each dNTP, 2 U/ml Taq polymerase with 13 buffer, 0.4
mM sense primer (59-ATGGCTACAAGGCTCCTCTGGTA-
39), and 0.4 mM antisense primer (59-CACGTGGTCAGGGAA-
GAA-39). 1 ml of the first PCR reaction was transferred to a sec-
ond reaction containing 2 mM MgCl2, 0.1 mM of each dNTP, 2
U/ml Taq polymerase with 13 buffer, 0.4 mM sense primer (59-
AATCTGCAGAATTCAAAAGTCATTCA-39), and 0.4 mM
antisense primer (59-AATCTGCAGCACGAGGGTAGCCTT-
TTG-39). cDNA was added to a reaction mixture containing 4
ml Dye Terminator Ready Reaction Mix (PerkinElmer), and 1.5
pmol primer (59-CTGTGCTGAAGTGTCCTTCAAAC-39) and
amplified for 25 cycles of 968C for 10 s, 508C for 5 s, and 608C
for 4 min. Samples were separated on a 6.5% acrylamide gel in an
ABI 373 sequencing system and analyzed using the ABI Prism se-
quence 2.1.2 software (Applied Biosystems). The clone names
describe the cell the TCR sequence was obtained from, the re-
sponse (P 5 primary), the day (day 9), the animal, and the sample
number.
Results
Isolating PCC-specific Th Cells. To purify PCC-specific
Th cells directly ex vivo, we used a five-color flow cyto-
metric strategy that has been described in detail elsewhere
(4, 51). In brief, we focused on Va111Vb31 Th cells in
the draining LNs that have upregulated CD44 and down-
regulated CD62L in response to antigen (Fig. 1 A). By day
5 of the primary response, .80% of these cells express
highly restricted CDR3 regions that exhibit the canonical
attributes of peptide specificity (4). No such population
emerges in response to adjuvant only or in response to an
irrelevant protein antigen such as hen egg lysozyme (4, 51;
data not shown). Repertoire studies using direct staining
with MCC/I-Ek tetramers have validated the V region–
based strategy used in this study (McHeyzer-Williams, L.J.,
unpublished results). The great majority of Va111 MCC/
I-Ek tetramer–binding cells (.75%) at the end of the first
week after priming have upregulated CD44 and downreg-
ulated CD62L (one example displayed in Fig. 1 B). These
Va111 tetramer-binding cells express similar CDR3 re-
striction, with canonical features associated with PCC
specificity as seen with the V region–based strategy. As de-
scribed above, these tetramers are known to cross-link
TCR and deliver signals to the Th cells, and hence have
not been used for the subsequent analysis of function. Fur-
ther, using the V region–based strategy, antigen-specific Th
cells can be isolated directly ex vivo regardless of their af-
finity for peptide–MHC complexes.
Establishing Cytokine-producing Potential In Vivo. We
first examined the cytokine-producing potential of PCC-
specific primary responders (Fig. 2 A, Va111Vb31 cells
that upregulate CD44). We focused analysis on PCC-spe-
cific Th cells from day 9 of the primary response, 2 d after
peak cell expansion in vivo and before any significant local
Figure 1. Isolating PCC-specific Th cells directly ex vivo. (A) B10.BR
mice were immunized with 400 mg PCC in Ribi adjuvant. Cells from the
draining LNs were stained with Cy5PE-53-6.7 (anti-CD8), Cy5PE-M1/
70.15 (anti-CD11b), Cy5PE-6B2 (anti-B220), FITC-RR8.1 (anti-
Va11), APC-KJ25 (anti-Vb3), PE-Mel14 (anti-CD62L), and biotin-IM7
(anti-CD44) as described in Materials and Methods. Forward and obtuse
light scatter gates were used to exclude neutrophils and macrophages but
include T cell blasts. Cells stained with propidium iodide (PI) are ex-
cluded in the Cy5PE channel at acquisition. A representative probability
contour of Va11/Vb3–expressing T cells from an unimmunized animal
(Day 0) and an animal immunized 7 d earlier (Day 7) are shown. Va11/
Vb3-expressing T cells that have upregulated CD44 and downregulated
CD62L at each time point are displayed in the small insert box. (B) LN
cells from B10.BR mice labeled with MCC/I-Ek tetramers on day 8 after
priming as described above. KJ25 (anti-Vb3) blocks MCC/I-Ek labeling
and so cannot be used together with the tetramer. 5% probability contours
display 3.5% of cells binding MCC/I-Ek tetramers within the Va111 LN
cells (1.8% of LN cells; .95% CD4). 80% of Va111MCC/I-Ek1 cells are
CD44hiCD62Llo (right panel) and express CDR3 regions typical of anti-
gen binding (McHeyzer-Williams, L.J., unpublished results).1305 Panus et al.
Figure 2. Cytokine-expressing potential of PCC-specific primary and memory responders. (A) Cells from draining LNs of B10.BR mice at day 9 of a
primary response or day 3 of a memory response to PCC were isolated and cultured with or without PMA and ionomycin. Cells were stained with
Cy5PE-53-6.7 (anti-CD8), Cy5PE-M1/70.15 (anti-CD11b), Cy5PE-6B2 (anti-B220), FITC-RR8.1 (anti-Va11), APC-KJ25 (anti-Vb3), PE-Mel14
(anti-CD62L), and TR–Pgp-1(anti-CD44), then fixed, permeabilized, and stained for intracellular cytokines. The cells analyzed for cytokine expression
did not express B220, CD11b, or CD8 but expressed both Va11 and Vb3 TCR subunits. Cells expressing low and high levels of CD44 were analyzed
for intracellular cytokine staining as were the total Va112Vb32 cell population. (B) Representative 5% probability contours of Va11/Vb3-expressing
cells with high levels of CD44 expression cultured with and without PMA and ionomycin and stained for intracellular cytokines are shown. The proba-
bility contours for the cells cultured without PMA and ionomycin were used to determine the gates for cells expressing each cytokine. (C) The table
shows the percentage of cells (6 SEM) from day 9 of the primary response that stained positively for each cytokine after in vitro activation with PMA and
ionomycin (Iono). As CD44 levels do not change during the 4 h of culture, the Va111Vb31 CD44hi population of cells are the PCC-specific cells
primed in vivo, and the Va111Vb31 CD44lo cells are naive non–PCC-specific Th cells. The Va112Vb32 CD44hi cells are most likely antigen-experi-
enced cells that are not PCC specific but appear responsive to mitogen. The frequency of Va111Vb31 CD44lo cells (mean 6 SEM) from day 9 cultured
without PMA and ionomycin (Untreated) that stained positively for each cytokine was ,0.5%. Data represent three separate experiments. (D) The table
shows the percentage of cells (mean 6 SEM) within the PCC-specific and nonspecific subpopulations from day 3 of the memory response that stained
positively for each cytokine after in vitro PMA and ionomycin treatment. The frequency of cells cultured in the absence of PMA and ionomycin that
stained positively for each cytokine ranged from 0.1 to 1.0%.1306 Selective Cytokine Expression In Vivo
decline of specific cells. Short-term antigen stimulation in
vitro leads to rapid loss of TCR, which obscures our abil-
ity to isolate the PCC-specific Th cells and hence could
not be used in this study. We used short-term mitogen
stimulus in vitro to avoid the influence of antigen dose,
TCR affinity, or extensive culturing on the pattern of cy-
tokines produced (Fig. 2 B displays examples of the intra-
cellular cytokine label). These mitogenic stimuli deliver
powerful signals over 4 h in vitro, independent of TCR or
particular costimulatory requirements of the target cells.
Background staining for each reagent was estimated using
PCC-specific Th cells that were cultured without mitogen
(Fig. 2 B). Representative probability contours indicate
low background staining and the varied efficacy of mito-
gen treatment for the induction of IL-2, TNF-a, IL-4,
IFN-g, and IL-10 in the target population (Fig. 2 B; sum-
marized in C and D). Similar fluorescence ranges for nega-
tive staining were seen in CD44loVa111Vb31 cells (non–
PCC-specific naive) and helped to define background
staining for the reagents (data not shown; frequencies dis-
played in Fig. 2 C). Since CD44 levels do not change dur-
ing the 4 h of culture with PMA and ionomycin (28.0 6
Figure 3. Single cell sensitivity of the
RT-PCR assay. (A) Spleen cells from un-
immunized B10.BR or C57BL/6 mice
were isolated and activated with PMA and
ionomycin as described in Materials and
Methods. Activated cells were stained with
Cy5PE-53-6.7 (anti-CD8), Cy5PE-M1/
70.15 (anti-CD11b), Cy5PE-6B2 (anti-
B220), TR–Pgp-1(anti-CD44), and FITC–
CT-CD4 (anti-CD4). One half of the
spleen cells was fixed, permeabilized, and
stained for intracellular cytokines. Intracel-
lular cytokines were evaluated in the total
CD44hiCD41 cell population (B220, CD8,
and CD11b negative). The remaining half
of the spleen cells was kept unfixed. Single
CD44hiCD41 cells were isolated using the
same gating scheme as used for the fixed
spleen cells and were sorted directly into
cDNA reaction mix and analyzed by RT-
PCR. (B) Representative probability con-
tours of CD41 spleen cells cultured with
and without PMA and ionomycin and
stained for intracellular cytokines are
shown. The cells cultured without PMA
and ionomycin acted as a negative control
for the intracellular staining. The analysis of
IL-2, TNF-a, and IFN-g and the IL-4 and
IL-10 expression were obtained in separate
experiments. (C) Cloned cytokine DNA
was quantified, by OD260, titrated, and sub-
jected to two rounds of nested PCR using
optimized PCR primers and conditions.
PCR products from each dilution are
shown. The approximate numbers of single
strand molecules of input DNA in the high-
est detectable dilution for each cytokine are
as follows: 50 molecules of TNF-a control
DNA, 300 molecules of IL-4 DNA, 200
molecules of IFN-g DNA, 50 molecules of
IL-10 DNA, and 400 molecules of IL-6
DNA (data not shown). These numbers are
calculated using the size of input DNA and
the quantity of DNA added to the PCR re-
action. (D) The frequencies of cells with de-
tectable cytokine expression determined by
intracellular staining and RT-PCR are
compared. The proportion of PMA and
ionomycin–treated CD41CD44hi cells
(mean  6  SEM) that stained positively for
each cytokine is shown. The mean percent-
ages of CD41CD44hi cells (6 SEM) cul-
tured with PMA and ionomycin with de-
tectable cytokine message are also shown.
The frequencies were obtained from three
separate experiments.1307 Panus et al.
3.6% with PMA and ionomycin and 30.8 6 1.2% with-
out), the Va111Vb31CD44hi cells are PCC specific cells
primed in vivo, and the Va111Vb31CD44lo cells are na-
ive non–PCC specific Th cells.
The majority of antigen-experienced Th cells produced
IL-2 and/or TNF-a with only a minor compartment pro-
ducing IL-4, IFN-g, and IL-10 upon PMA and ionomycin
activation. This pattern of cytokine-producing potential in
PCC-specific cells can be attributed to antigen experience
for IL-2, IL-4, IFN-g, and IL-10 production, with clear
differences from the naive non–PCC-specific Th cells
(Va111Vb31CD44lo Th cells that do not express PCC-
specific CDR3 regions; Fig. 2 C). These naive non–PCC-
specific cells contained similar numbers of TNF-a–produc-
ing cells, but far fewer IL-2–producing cells and no IL-4–,
IFN-g–, or IL-10–producing cells. Further, there was no
evidence for Th1/Th2 polarity within the PCC-specific
Th cells, with similar frequencies of IL-4– and IFN-g–pro-
ducing cells. Therefore, this short-term mitogen restimula-
tion assay provided a distinct and quantitative signature of
the mitogen-induced cytokine-producing potentials for
PCC-specific Th cells with high level IL-2 and TNF-a–
producing capacity, low IL-4, IFN-g, and IL-10, and no
Th1/Th2 polarity.
We next turned to the PCC-specific memory response
to ask whether there was an enrichment for preferred cy-
tokine-producing potential. Animals were rested for 8 wk
after initial priming and then boosted with a second prim-
ing dose of antigen in adjuvant. We have shown previously
that PCC-specific clonal expansion in this memory re-
sponse is accelerated and reaches similar peak cell numbers
by day 3 in the draining LNs, with no evidence for signifi-
cant decline in specific cells until day 6 of the memory re-
sponse (reference 3; see Fig. 4 A). The frequencies of cy-
tokine-expressing cells in the total CD44hi cells (.85%
CD41Va112Vb32) and the memory PCC-specific com-
partment (CD44hiVa111Vb31) were significantly different
for IL-2 (P 5 0.03), IL-4 (P 5 0.01), IFN-g (P 5 0.0001),
and IL-10 (P 5 0.01). These data argue further for a dis-
tinctive signature of mitogen-induced cytokine-producing
potential associated with PCC responsiveness versus the to-
tal antigen-experienced pool (total CD44hi cells). Consid-
ering the PCC-specific Th cell compartment, there was no
increase in the frequency of IL-2, TNF-a, IL-4, or IFN-g
Figure 4.  Kinetics of PCC-specific cytokine mRNA expression di-
rectly ex vivo. (A) The frequency of CD44hiCD62Llo Va11/Vb3-express-
ing T cells and total cell numbers within the LNs for the corresponding
animal were used to calculate the total number of PCC-specific Th cells
over the course of the primary (left) and memory (right) response. The
mean (6 SEM) for two to five animals are shown at each time point. (B)
cDNA was synthesized from 100 CD44hiCD62Llo Va11/Vb3-expressing
Th cells sorted at each time point of the primary and secondary responses
(days 3–13 after the primary and days 2–4 after the memory immuniza-
tion). After two rounds of nested PCR, PCR products were viewed by
ethidium bromide–stained agarose gels. PCR products, representative of
two or three experiments, are shown for each time point. Naive Va11/
Vb3-expressing Th cells (CD44loCD62Lhi) were also sorted at each time
point and analyzed for each cytokine. Results of this analysis are repre-
sented for day 7 of the primary response (7R) and day 4 of the memory
response (4R). Lane 2, PCR samples that did not contain cDNA; lane
1, PCR samples that contained cloned cytokine cDNA that was analyzed
as a positive control for size. (C) A summary of the RT-PCR analysis of
100 cell samples is presented. Each graph shows the percentage of samples
that resulted in a product after two rounds of PCR. Two to seven samples
were analyzed at each time point for the presence of each cytokine. Sam-
ples labeled 7R (day 7, primary), 4R (day 4, memory), and day 0 con-
tained cells with the CD44loCD62Lhi, resting phenotype. Lane 2, sam-
ples that did not contain cDNA.1308 Selective Cytokine Expression In Vivo
producers between the peak of the memory response (Fig.
2 D) and the peak of the primary response (Fig. 2 C). IL-10
was an exception, with significantly greater frequencies at
day 3 of the memory response (P 5 0.01). Thus, the ex-
panded population of PCC-specific memory response Th
cells contains frequencies of cells with mitogen-induced
cytokine-producing potentials similar to its primary re-
sponse counterpart population.
Cytokine mRNA Expression at the Single Cell Level. Al-
though mitogen responsiveness in vitro reveals some as-
pects of functional potential in the antigen-specific com-
partment, it does not accurately represent the pattern of
cytokine expression in vivo. It was also clear from the un-
treated controls in the previous experiments (Fig. 2 B) that
the intracellular staining for cytokine proteins was not sen-
sitive enough to detect the presence of cytokine protein in
individual cells directly ex vivo. Further, when T cells
stimulated by antigen and antigen-presenting cells in vitro
are dissociated from the antigen-presenting cells, they stop
secreting cytokines. This may also occur when single cell
suspensions are prepared from LNs of immunized animals,
although this has not been tested directly. For these reasons,
we chose to focus on cytokine mRNA expression directly
ex vivo. We also took care to process all cell samples at 48C
to minimize mRNA degradation. Therefore, to evaluate
the frequency of PCC-specific Th cells expressing cytokine
mRNA directly ex vivo, we developed a single cell RT-
PCR assay for a spectrum of T cell–derived cytokines.
To evaluate the sensitivity of the RT-PCR assays, we
compared the frequency of mitogen-induced cytokine-
producing CD44hi Th cells (regardless of TCR expression)
using intracellular staining for protein by flow cytometry to
the frequencies obtained after single cell sorting and RT-
PCR (Fig. 3 A). Representative probability contours indi-
cate low background staining and the varied efficacy of mi-
togen treatment for induction of IL-2, TNF-a, IL-4, IFN-g,
and IL-10 in the target population (Fig. 3 B; summarized in
D, first two columns). The sensitivity of the PCR reaction
across the different cytokine targets was similar on cloned
cDNA, detecting between 50 and 300 cDNA molecules
(Fig. 3 C; details in the figure legend). Interestingly,
the frequency of IFN-g–producing CD41 cells appeared
higher for these splenic samples than the estimates in the
draining LNs (Fig. 2). More importantly, the frequency of
single cells that expressed mRNA for each of the different
cytokines was similar to the frequency of cells expressing
cytokine protein as assessed by flow cytometry (Fig. 3 D;
compare last two columns). The RT-PCR assay for IL-4
and IL-10 appeared somewhat more sensitive than the flow
cytometric assay (most likely due to the low level of pro-
tein produced under these culture conditions; see flow pro-
files in Fig. 3 B). Overall, the RT-PCR assay was reliable
to the single cell level and the presence of mRNA corre-
lated well with production of protein.
Kinetics of Cytokine mRNA Expression In Vivo. We next
sorted small populations of PCC-specific Th cells (100–200
cell samples) across the primary response (as depicted in
Fig. 4 A) to assess the emergence and decline of cells ex-
pressing a range of cytokine mRNA. As the RT-PCR as-
say was sensitive to the single cell level, a negative sample
would represent a frequency of ,1%, which would not be
pursued further at the single cell level. As assessed in the
small populations, cytokine mRNA appearance was stag-
gered over the first week of the primary response (Fig. 4, B
and C). This pattern is best illustrated in Fig. 4 B for one
primary response time course, and is summarized for three
independent experiments in Fig. 4 C. IL-2 mRNA ap-
peared earliest and consistently in 100 cell samples from day
3. Its prevalence in samples gradually declined to day 9 and
was absent by day 11 (Fig. 4 C). IL-4 mRNA was next to
appear, occasionally detected at day 3 but consistently
present in all samples from days 5–13. IFN-g was the next
cytokine to appear, detected occasionally at day 5, increas-
ing to peak prevalence at day 9, declining markedly by day
11, and absent at day 13. In contrast, IL-10 and IL-6
mRNA appeared sporadically across the primary response
in only 20% of samples (n 5 34 samples for each cytokine,
including 14 samples of 200 cells) (IL-6 RT-PCR was sen-
sitive to 400 cDNA molecules; data not shown). This spo-
radic appearance of IL-6 and IL-10 is most likely due to
very low frequencies of these producers after initial prim-
ing. TNF-a mRNA was found in all samples (including
the naive Th cell populations) so was not amenable to ki-
netic analysis using small populations. Thus, the small pop-
ulation RT-PCR analysis offers some resolution to the
orchestrated appearance and disappearance of cytokine
mRNA in antigen-specific Th cells during the primary im-
mune response.
In the memory response, antigen-driven expression of cy-
tokine mRNA in vivo was clearly accelerated (Fig. 4, B and
C; second column). All cytokines were present at the earliest
memory response time point (day 2), with the exception of
IL-6, which was absent at all time points. Cytokine produc-
tion was restricted to the PCC-specific Th cell compart-
ment, with very little background in the naive Th cells
(background cell samples Va111Vb31CD44loCD62Lhi: 0/76
samples analyzed for either IL-4, IFN-g, or IL-6; 2/27 sam-
ples of IL-2; and 1/23 samples for IL-10). It also appeared
that cytokine production in either primary or memory re-
sponse was not grossly polarized to Th1 or Th2 patterns by
the Ribi adjuvant system as suggested by the in vitro restim-
ulation assay (Fig. 2). Therefore, with the exception of IL-6,
the range of cytokines seen in the memory response recapit-
ulated that found in the primary response, albeit accelerated
and more sustained in expression.
Frequency of Cytokine-expressing Cells Directly Ex Vivo.
Although the pattern of memory response cytokines was
similar to the primary response, it was possible that the fre-
quency of preferred cytokine-producing cells was en-
hanced in the memory compartment. To address this pos-
sibility, we first sorted single PCC-specific Th cells from
primary response day 9 for RT-PCR analysis of cytokine
mRNA (Fig. 5). The representative agarose gel for each
cytokine indicates that whether single cells or 100-cell sam-
ples were used, maximal PCR product of the right size was
obtained (compare Figs. 4 B and 5 A). Hence, the nested1309 Panus et al.
RT-PCR strategy was not quantitative, but sufficiently
sensitive to allow direct ex vivo estimation of effector Th
cell frequencies. Also note that wells 1 and 12 have no
cells sorted into the cDNA reaction mix, and that each
gel presented comes from a different set of single cells
(i.e., 1/5 wells are always processed alongside positive
samples as a negative control). In the population studies,
both IL-2 and IL-10 were detected infrequently (Fig. 4
C) so were not pursued for the single cell analysis at this
primary time point. In contrast, TNF-a could be assessed
at the single cell level because the background frequencies
were 0.9 6 0.5% (n 5 240; naive Th cells: Va111
Vb31CD44lo CD62Lhi). Surprisingly, far fewer PCC-spe-
cific Th cells expressed TNF-a mRNA directly ex vivo
(2.5 6 1.1%; Fig. 5) than were capable of producing it in
vitro (66 6 8%; Fig. 2). Thus, IL-2 and TNF-a that were
readily induced in vitro appeared more tightly regulated
in vivo.
IL-4 was the most prevalent cytokine at day 9 of the pri-
mary response (10.2 6 4.6%; Fig. 5 B). Considering the
greater sensitivity of the RT-PCR assay for this cytokine,
the frequency of IL-41 cells was similar to that seen after in
vitro restimulation (5.0 6 2.0%; Fig. 2 C). In contrast,
there were at least 25-fold fewer PCC-specific Th cells ex-
pressing IFN-g mRNA directly ex vivo (0.4 6 0.4%; Fig.
5 B). PCC-specific Th cells with IFN-g mRNA were de-
tected in only 1 of 4 animals examined for frequency at this
time point (1/270 cells screened). Although no dramatic
Th1/Th2 polarity could be seen in vitro, marked skewing
to Th2-like polarity in the PCC-specific Th cell response
occurred at the level of mRNA expression in vivo.
Using the same single cell approach, we next sorted
PCC-specific Th cells from day 3 of the memory response
to evaluate any change in frequencies of cytokine-produc-
ing cells. Although IL-2 and IL-10 were undetectable at
the peak of the primary response, they were both present at
low but reproducible frequencies at the peak of the mem-
ory response (2.6 6 0.5 and 3.6 6 1.7%, respectively; Fig.
5 B). TNF-a–expressing cells were also present at higher
frequencies in the memory response compared with the
primary (7.0 6 1.8 and 2.7 6 1.2%, respectively; Fig. 5 B).
Frequencies of IFN-g–expressing cells in the memory re-
sponse increased 10-fold above estimations for the primary
response (3.9 6 1.5 and 0.4 6 0.4%, respectively; Fig. 5
B). This increase in frequency of IFN-g–expressing cells
occurred with no change in the frequency of IL-4–express-
ing memory Th cells, which remained at maximal levels
(11.1 6 0.6 and 10.2 6 4.6%, primary to memory; Fig. 5
B). With the exception of IL-4, all frequencies of memory
Th cells expressing particular cytokine mRNA were sub-
stantially lower than seen in the same cells after mitogen re-
stimulation in vitro (compare with Fig. 2 D, last column).
Therefore, the cytokine-producing potentials of memory
response PCC-specific Th cells only changed for IL-10,
whereas the change in frequencies of cells expressing cy-
tokine mRNA in vivo was more widespread. Taken to-
gether, these changes in frequency underscore the role of
the microenvironment in regulating local cytokine produc-
tion and demonstrate the selective expression of Th cell
function in vivo.
Efficacy of Single Cell RT-PCR Frequency Estimations. It
was possible that we were underestimating frequencies of
cytokine-expressing cells with the single cell RT-PCR as-
say. First, to check the efficiency of the cell sorting itself, an
actin-specific RT-PCR served as one external control, in-
dicating that 70–80% of the wells contained at least one cell
(Fig. 5). Direct microscopic examination of 72-well plates
after single cell sorting (same as used for the cDNA synthe-
sis reaction) indicated that 75% of the wells contained one
cell at its base and in no cases did we see more than one cell
in each well (n 5 180). As another check on the sensitivity
of the RT-PCR for single cells directly ex vivo, we diluted
the cDNA from single cytokine-expressing cells into subse-
quent PCR reactions. We first assessed frequencies for cy-
Figure 5. Frequency of cyto-
kine-expressing PCC-specific Th
cells directly ex vivo. (A) Single
CD44hiCD62Llo V a11/Vb3-
expressing T cells were sorted
directly into wells of Terasaki
plates containing cDNA reaction
mix. After cDNA synthesis and
two rounds of nested PCR,
PCR products were viewed on
ethidium bromide–stained aga-
rose gels. Examples of PCR
products obtained after RT-
PCR analysis of a single row of
cells sorted at day 2 of the mem-
ory response are shown for IL-2,
TNF-a, IL-4, IFN-g, IL-10,
and actin. A different row of cells was analyzed for each cytokine and actin. Cells were not sorted into the first (1) or last (12) wells of each row, and these
samples were processed alongside the cell samples as negative controls. PCR products from cloned cytokine cDNA are shown as a positive control for
size (1). Actin was used to control for the efficiency cDNA synthesis and cell sorting. (B) Single, CD44hiCD62Llo Va11/Vb3-expressing T cells were
sorted at day 9 of the primary response and day 4 of the memory response and analyzed by RT-PCR. The table shows the total number of single cells an-
alyzed for each cytokine at each time point. The mean percentage (6 SEM) of cells with detectable cytokine mRNA from three separate experiments are
shown. Examples of frequencies obtained from individual experiments at day 3 of the memory response are as follows: IL-2: 3.3, 1.7, 2.8; TNF-a: 8.0,
3.3, 11.7, 5.0; IL-4: 11.7, 11.7, 10.0; IFN-g: 6.7, 3.3, 1.7; and IL-10: 0.8, 1.7, 3.7, 8.3.1310 Selective Cytokine Expression In Vivo
tokine-expressing cells using half of the original cDNA and
detected no change in expected frequency of positives for
each cytokine. A significant number of these positives
could still be detected using 1/5 of the cDNA from a single
cell (45% TNF-a, 50% IL-4, 29% IFN-g, 35% IL-10).
Hence, the RT-PCR assay is robust for this panel of cy-
tokine mRNA.
Next, we assessed whether the RT-PCR assay could de-
tect in vivo antigen-activated Th cells (as opposed to the in
vitro–activated cells shown in Fig. 3). We sorted either
three or six antigen-specific cells per well and evaluated the
corresponding increase in the frequency of positives. If we
were missing many single positive events because they
were below threshold sensitivity, when we increased cell
input the observed frequency would now exceed the ex-
pected frequency (extrapolated from the single cell analy-
sis). We found a high concordance for TNF-a and IL-10
(expected versus observed: 18 vs. 20% at 3 cells per well,
and 12 vs. 15% at 6 cells per well, respectively) with a
slightly lowered frequency for IL-4 and IFN-g than ex-
pected (expected versus observed: 30 vs. 14.4% at 3 cells
per well, and 18 vs. 7.1% at 6 cells per well, respectively),
which is best explained by variability between animals and
not as an overestimation of frequencies at the single cell
level. Thus, it was highly unlikely that we were underesti-
mating the frequency of cytokine-producing Th cells in the
target population.
Dynamics of Cytokine Expression during the Memory Re-
sponse. In the next series of experiments, we quantified
the dynamics of cytokine expression across the course of
the memory response. The first time point analyzed was
day 2 (before the peak of cell expansion) through to day 6
when there is evidence for the decline of PCC-specific Th
cells in the draining LNs (Fig. 6). The frequency of IL-21
cells was surprisingly low considering the extent of clonal
expansion in the memory response (days 0–2: 10-fold, and
days 2–4: 7.5-fold; Fig. 4 A). In contrast, the peak fre-
quencies for TNF-a1 cells at day 2 (10.8 6 4.6%; Fig. 6)
resembled the higher frequencies of IL-41 cells in both
primary and memory responses. Hence, TNF-a may pro-
vide the stronger proliferative drive to memory Th cells
than IL-2. Regarding the cytokines more involved in B
cell differentiation, frequencies for IL-4, IFN-g, and IL-10
remained relatively stable across the memory time course.
IL-41 Th cells represent 11 6 1.1% of antigen-specific
memory responders by day 2, with an average across days
2–6 of 10.4 6 0.7% (n 5 1,180 single cells across 12 sepa-
rate animals). IFN-g is present at lower but stable frequen-
cies across days 2–6 at 3.2 6 0.4% (n 5 840 across 12 sep-
arate animals). IL-101 Th cells were present at even lower
frequencies, but were also relatively stable across days 2–6
at 2.0 6 0.6% (n 5 1,140 single cells across 13 separate an-
imals). These extended frequency data indicate that we
have not simply missed the peak of cytokine production
for the panel analyzed and provide high confidence esti-
mations for the low frequencies reported. Further, the sta-
bility of frequency over large increases and decreases in to-
tal cell numbers suggests that expression of particular
functions may assort with the clonal progeny of memory
responders.
Functional Commitment among Clonal Progeny. To more
directly evaluate clonal relatedness among cytokine-express-
ing Th cells and to scrutinize the relationship between
TCR structure and Th cell function, we next examined
Figure 6. Dynamics of cytokine expression across the PCC-specific
memory response. Single, CD44hiCD62Llo V a11/Vb3-expressing Th
cells were sorted at days 2, 3, 4, and 6 of the memory response. The per-
centage of single cells that had detectable cytokine cDNA at each time
point is shown in the first column of graphs (mean 6 SEM). The number
of single cells analyzed at each time point is presented at the top of each
graph. At day 0, the number of Va11/Vb3-expressing T cells with a
CD44hiCD62Llo phenotype was too low to sort single cells for analysis
(*). Results from population analyses of CD44loCD62Lhi Va11/Vb3-
expressing Th cells show that the percentage of naive Th cells that express
IL-2, IL-4, IL-10, or IFN-g mRNA at any time point is low, whereas the
percentage that express TNF-a mRNA is 0.9 6 0.5%. Single cells were
not analyzed for IL-2 at day 4 since population analysis predicts ,1% of
cells express this cytokine (see Fig. 4). The total number of Va111Vb31
CD44hiCD62Llo cells with detectable cytokine cDNA was determined for
each mouse using the percentage of cytokine-expressing cells and the to-
tal number of activated cells in the inguinal and periaortic LNs. The total
numbers (mean 6 SEM) are presented for each cytokine at each time
point of the memory response in the second column of graphs. Day 0 es-
timations are based on frequencies of ,1% for each cytokine in the total
CD44loCD62Lhi Va11/Vb3-expressing Th cell compartment.1311 Panus et al.
the TCR-b chain CDR3 regions of individual cytokine-
expressing cells (Fig. 7). We focused this repertoire study
on TNF-a1 and IL-41 antigen-specific Th cells from day 9
of the primary response. Half of the cDNA from individual
Th cells was used for the cytokine-specific RT-PCR, and
the TCR-b chain was amplified from the remaining
cDNA of positive cells and then directly sequenced
through the CDR3 region. Three types of results can be
seen in the CDR3 sequence data. First, the restriction of
CDR3 length (nine amino acids), J region usage (Jb1.2 and
Jb2.5), and amino acid residues in positions b100 (N) and
b102 (A/G) are generally in accord with expected PCC-
specific CDR3 structures across both sets of cytokine-
expressing cells. Next, the CDR3 sequence used by a cy-
tokine-expressing PCC-specific Th cell can be compared
with the total set of PCC-specific TCR analyzed previ-
ously for repertoire alone (4). The TNF-a1 clone express-
ing a glutamine residue seen at b100 (P9.C4 and P9.C5;
Fig. 5) is atypical, with only 4% of total PCC-specific cells
expressing this residue (after day 5 primary n 5 313 [refer-
ence 4]) and rarely paired with alanine at b102. The set of
IL-41 cells may preferentially express TCR using Jb2.5,
with 41% using this J segment compared with 20% of total
PCC-specific Th cells (after day 5 primary n 5 313 [refer-
ence 4]). This type of analysis suggests that particular TCR
structures may influence the commitment to Th cell func-
tion in vivo.
Finally, in both sets of cytokine-expressing Th cells there
were several examples of repeat sequences (at the base pair
level; Fig. 7, enclosed by the square brackets at the end of
the panels). These repeat CDR3 sequences are indicative of
repeat TCRs from different cells in vivo and not generated
artificially in vitro (this is rigorously controlled for in the
experimental design; see Materials and Methods for more
details). In general, junctional sequence in the TCR b
chain can be used as an indicator of clonal relatedness; how-
ever, in our experience the NNA motif seen in many of the
TCR b chains of PCC-specific Th cells (with the same nu-
cleotide sequence) can pair with distinct TCR a chains and
should not be used as an indicator of clonality in this re-
sponse (4). Nevertheless, for each of the cytokines analyzed
there was at least one other example of repeated sequences
within individual animals using less typical sequences (QGA
for TNF-a and NWG for IL-4). As we have amplified and
sequenced the TCR b chain from only a few IL-4– and
TNF-a–producing representatives from individual mice,
the presence of repeat sequences provides strong evidence
for functional commitment among clonal progeny.
Figure 7. Commitment to TNF-a or IL-4 among
clonal progeny. Single, CD44hiCD62Llo Va11/Vb3-express-
ing T cells were sorted at day 9 of the primary response
and cDNA was immediately synthesized. One half of the
single cell cDNA sample was analyzed for the presence of
IL-4 or TNF-a cDNA. If a sample contained detectable
IL-4 or TNF-a, the remaining cDNA was subjected to
two rounds of nested PCR to amplify the TCR Vb3
cDNA. The Vb3 PCR product was sequenced, focusing
on the CDR3 region as described. Nucleotide and pre-
dicted amino acid sequences obtained from 21 single cells
are grouped by the cytokine they expressed. The TCR-b
amino acid positions 100 and 102 are highlighted in each
sequence. The sequences of the CDR3 and portion of the
J element that is not a part of the CDR3 are shown with
the number of the particular J element within this TCR.
PCC-specific cells from individual animals that have the
same TCR-b nucleotide sequence are grouped with
square brackets at the end of each sequence.1312 Selective Cytokine Expression In Vivo
Discussion
This study quantifies the antigen-dependent develop-
ment of Th cell function as frequencies of mitogen-
induced cytokine-producing PCC-specific Th cells and
frequencies of PCC-specific Th cells expressing cytokine
mRNA directly ex vivo. To our knowledge, these results
provide the first direct frequency estimates of Th cell func-
tion for nontransgenic Th cells primed in vivo with anti-
gen. Comparing Th cell function in the primary and
memory response offers some surprising insights. The fre-
quencies of PCC-specific Th cells able to produce B cell
differentiation factors such as IL-4, IFN-g, and IL-10 were
remarkably low directly ex vivo and still low after powerful
restimulation in vitro. Even in the memory response, very
few PCC-specific memory responders expressed this capac-
ity in vivo. Although the frequency of functionally com-
mitted Th cells was clearly higher in the antigen-experi-
enced compared with the naive Th cell compartment, it
was notable that this level of commitment appeared to be
set by day 9 after initial encounter with antigen. In addi-
tion, there was little evidence for the selective preservation
of preferred primary effector function into the memory
compartment. Hence, the memory Th cell compartment is
comprised of functionally specialized Th cell precursors
from which the memory response to antigen rechallenge is
drawn. Thus, functional potential is a consequence of the
initial antigen/adjuvant experience, whereas expression of
preferred function depends on the particular needs of the
host at the time of antigen exposure.
Direct Frequency Estimation for Antigen-specific Th Cell
Function. More accurate analysis of T cell function ac-
companies the ability to isolate antigen-specific T cell di-
rectly ex vivo. The introduction of peptide–MHC tetra-
mers (52) has provided a new level of discrimination to the
analysis of complex T cell populations, as they have been
elegantly exploited in the study of MHC class I–restricted
T cell responses in both humans (52, 53) and mice (54–56).
The MHC class II versions of this new class of reagent have
been more difficult to produce and less widely applied (39,
57–59). Effective labeling with these multimeric reagents
depends on adequate TCR affinity, and they are also
known to deliver signals through the TCR upon binding
(40). Further, the very low frequencies of antigen-specific
Th cells (compared with antiviral CTL responses) makes
reliable flow cytometric isolation from nontransgenic ani-
mals difficult. In the current study, we chose an earlier
strategy for PCC-specific Th cell isolation using V region
gene expression and comodulation of activation markers (3,
4, 51). We have shown that these PCC-specific Th cells
bind MCC/I-Ek tetramers (Fig. 1; McHeyzer-Williams,
L.J., unpublished results) and more importantly, that the V
region–based strategy does not induce calcium transients
during cell isolation (41). Thus, starting with purified anti-
gen-specific Th cells allowed us to quantify directly the fre-
quency of cells within the responding populations that
could either produce a particular cytokine in vitro or ex-
press a particular cytokine mRNA in vivo.
Development of Functional Potential in the Th Cell Compart-
ment. The mitogen restimulation assay quantifies some
aspects of acquired functional potential due to antigen ex-
perience. Clearly, PMA and ionomycin stimulation is a
powerful mitogenic signal to T cells and may not reflect
the true spectrum of functional potentials in vivo. Never-
theless, differences in the response to this mitogen are seen
across the different populations of Th cells analyzed in this
study and provide one distinct signature of antigen-depen-
dent changes in functional potential. Accurate analysis of
Th cell function in vitro remains difficult using any strat-
egy, mainly due to the complex microenvironmental con-
ditions in vivo that remain poorly defined, especially in the
later phases of a developing immune response.
The early studies of Mosmann and Coffman (24) orga-
nized Th clones into two broad categories based on the
pattern of cytokines they produced, predicting either a cell-
mediated (Th1) or humoral (Th2) focus to the subsequent
adaptive immune response. This functional lineage com-
mitment appears to be based on adjuvant, the route of im-
munization, and the strength and duration of antigen signal
(60–62). In the current study, we use a nonreplicating pro-
tein antigen and a nondepot adjuvant that was developed to
generate high titer antibody responses (42, 43). Using the
same immunization regimen, we recently quantified a vig-
orous hapten-specific memory B cell response with ample
evidence of IgG1-, IgG2a-, and IgE-expressing memory B
cells, further demonstrating the humoral bias of this proto-
col and efficacy of the Ribi adjuvant system (63). Despite
this bias towards a humoral response, there was no evi-
dence for skewed acquisition of Th2 functional potential in
the population as revealed by mitogen stimulation in vitro.
These data are consistent with many studies in which there
is no evidence for Th1/Th2 lineage commitment at the
single cell level (26–30). The Ribi adjuvant used in the
current study promotes both IFN-g–controlled IgG2a (46)
and IL-4–controlled IgG1 and IgE (46, 47) and hence, may
explain codevelopment of Th cells with these characteris-
tics. Nevertheless, these data clearly indicate stable com-
mitment for the capacity to produce both Th1 and Th2
cytokines within the PCC-specific memory Th cell com-
partment.
Even though the immunization regimen used in this
study biases towards humoral immunity, very few PCC-
specific Th cells were committed to the production of cy-
tokines that regulate B cell differentiation (IL-4, IFN-g,
and IL-10). In this study, using powerful in vitro re-stimu-
lation conditions, it is unlikely that we are greatly underes-
timating the cytokine-producing potentials of the PCC-
specific cells. Furthermore, there was no enrichment in the
memory response for Th cells with the capacity to produce
IL-4 and IFN-g, suggesting no heightened need for these
cytokines in the memory B cell response. IL-10 was the
exception to this pattern, with evidence for a significant in-
crease between primary and memory response. This Th
cell function may be selectively preserved due to its ability
to promote plasma cell differentiation (49); however, ca-
pacity for IL-10 production is still only found in ,10% of1313 Panus et al.
the PCC-specific memory response Th cells. Thus, we
must conclude that the low frequencies of cytokine-pro-
ducing Th cells that we see in response to PCC are suffi-
cient to promote B cell differentiation and memory B cell
responses in vivo.
The low and relatively stable frequencies for potential
cytokine production may reflect T cell–intrinsic mechanisms
for regulating functional commitment as demonstrated for
IL-4 (16, 17). It is also possible that other mechanisms
more influenced by extrinsic factors, such as gene-specific
chromatin remodeling (22, 23, 64, 65) and expression of
key transcription factors (19, 21), are differentially regu-
lated in specialized microenvironments of the developing
immune response. Nevertheless, established potentials for
cytokine production are evident early after initial antigen
priming, with little evidence for selection of preferred
function into the long-lived memory Th cell compartment.
These data are consistent with the stable acquisition of
in vitro–induced patterns of cytokine production demon-
strated for TCR transgenic Th cells in adoptive transfer
models (12, 33, 66). Thus, if selection for functional poten-
tial is a major component of the primary response to PCC,
it must occur very rapidly after initial antigen exposure.
Expression of Cytokine Function In Vivo. The single cell
RT-PCR assay provides a direct view of cytokine expres-
sion patterns in vivo and quantifies the frequency of PCC-
specific cells actively expressing cytokine mRNA directly
ex vivo. This analysis provides a “snapshot” of activity,
precisely at the time of organ disruption for the preparation
of cell suspensions. We argue that the frequency of cells ex-
pressing mRNA for particular cytokines directly ex vivo
offers a good estimate for cells with this activity in vivo.
Regardless, this estimate of cytokine activity in vivo will
underestimate the full range of Th cell activities, as they
only measure frequencies of PCC-specific Th cells actively
engaged in cognate interactions at the time of analysis (67,
68). Although antigen specificity was not directly evaluated
in previous studies (13, 69, 70), the low frequencies for cy-
tokine producers reported here are consistent with these
earlier estimates. Due to low frequencies and the rapid ap-
pearance of IL-2 in vivo (70–72), the peak of primary re-
sponse IL-2 production may not be visible using our cur-
rent model. TNF-a appeared at higher frequencies than
IL-2 in the memory response, and may suggest a more
dominant role for TNF-a in memory Th cell expansion.
Although there was no evidence for Th1/Th2 polarity at
the level of lineage commitment, there was a clear propen-
sity for IL-4 over IFN-g expression directly ex vivo during
the primary response. IL-4 also appeared earlier and per-
sisted for longer than IFN-g after initial challenge, further
indicating a dominant role in this PCC-specific Th cell re-
sponse. However, in the memory response both cytokines
reappeared rapidly. IFN-g–expressing cells appeared at
higher frequencies in memory responders with no change
in IL-4 prevalence. Thus, expression of preferred function
appears regulated by the response microenvironment and
not through the development of preferred functional po-
tentials. The increase in expression with no change in po-
tential was also found for IL-2 and TNF-a. In contrast,
there were increases in both the potential for production
and the frequency of memory responders expressing IL-10.
Although IL-6 production in vitro was not analyzed, ex-
pression was detected at low levels in the primary response
but was absent in the memory. These latter two cytokines
may represent exceptions in which particular Th cell func-
tions are selectively retained (or lost) in the primary re-
sponse or through selective expansion in the memory re-
sponse. Therefore, it is clear that extrinsic factors regulate
the cytokine expression pattern in vivo; however, in some
cases the fate of antigen-experienced precursors may be de-
termined by their functional potential.
Relationship of TCR Structure to Function. TCR recog-
nition of peptide–MHC is central to synapse formation and
the initiation of adaptive immunity. It is clear that the mi-
croenvironmental context of coreceptor, costimulation,
and cytokine environment can greatly influence the devel-
opment of function (14). It also appears that different anti-
gen doses under identical culture conditions can drive dif-
ferent functional outcomes (60, 61). These stimuli mainly
change the strength and duration of TCR signaling (62). A
recent study also indicates that very slight changes in TCR
structure can have major influence on Th cell differentia-
tion pattern (73). Our initial TCR structure–function study
focuses on the PCC-specific Th cells that express either IL-4
or TNF-a at day 9 of the primary response. There was
some indication that these Th cells as a group differ slightly
in sequence features from the total PCC-specific popula-
tion and hence lend support to the association discussed
above. These studies are in their early phase and require
many more sequences before any strong conclusions can be
drawn. The stronger and perhaps more informative data lie
in the evidence for clonal progeny at this early primary re-
sponse time point. Here, we sample very few cytokine-
expressing cells (compared with the total compartment
present in any individual animal) and find evidence for
clonal progeny. The extent of expansion for each commit-
ted clone must already be large by day 9, and suggests that
commitment to function for these clones must have oc-
curred some considerable time earlier. Thus, commitment
to function and perhaps selection for preferred function
may occur with similar kinetics to the selection for pre-
ferred TCR structure (3, 4).
Development and Delivery of Antigen-specific Th Cell Func-
tion. These studies help to distinguish between the devel-
opment of Th cell functional potential and the delivery of
specialized function in vivo. Development of potential as
assessed by mitogen stimulation in vitro appears set very
early after initial priming, and if there is any preferential se-
lection for function, it is over very rapidly for most cyto-
kines. Delivery of specialized function as assessed by the
RT-PCR assay reveals different patterns of expression
across primary and memory responses. Cytokine-express-
ing Th cells emerge at low frequencies in a staggered and
somewhat polarized pattern in the primary response and, as
expected, reemergence in the memory response is rapid
with changes in frequencies evident for many of the cyto-1314 Selective Cytokine Expression In Vivo
kines tested. These data indicate a complex organization of
Th cell function that appears regulated through both the
differential development of functional potential after initial
priming and the controlled expression of these potentials
through dynamic microenvironmental influences. 
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